1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6D13A56C4C6A8BA3400258D0E004A3665
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/D13A56C4C6A8BA3400258D0E004A3665?OpenDocument
18
19OpenDocument
2018.97.9.172
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




» Products & Services » » Medical Affairs » Structure, Staffing and Budgets

Document Excerpt: Activating Medical’s Customers: Boosting Performance With Content Strategy and Innovation

DB Image

ID: MD-992


Features:

8 Info Graphics

11 Data Graphics

150+ Metrics

5 Narratives


Pages/Slides: 4


Published: 2025


Delivery Format: Online PDF Document


 

License Options:


Download FREE Excerpt

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
To download this excerpt, click "Download Free Excerpt".

To return to the study abstract to purchase the full study -
click here

This excerpt includes research findings and metrics from document #5892 “Activating Medical’s Customers: Boosting Performance With Content Strategy and Innovation”.

Industries Profiled:
Pharmaceutical; Biopharmaceutical; Biotech; Manufacturing; Diagnostic; Health Care; Service; Medical Device; Clinical Research; Laboratories


Companies Profiled:
AbbVie; Alnylam Pharmaceuticals; AstraZeneca; Axsome Therapeutics; Biogen; bioMérieux; BIOVIIIx; Boehringer Ingelheim; Eisai; EMD Sereno; EVERSANA; Exact Sciences; ImmunityBio; Ipsen; Jazz Pharmaceuticals; Johnson & Johnson; Lantheus; Merck & Co.; Merck KGaA; Organon; Orion Pharmaceuticals; Otsuka; Premier Research; Relay Therapeutics; Sanofi; Sobi; Stallergenes Greer; Taiho Oncology; Vertex Pharmaceuticals; Xenon Pharmaceuticals

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.